Showing results (2051-2060 of 2,443) with videos related to

Sort By:
Pageof 245
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trialR S Herbst, P Baas, J L Perez-Gracia, et al.
Physical Review Letters|May 9, 2020
Constraining the External Capture to the ^{16}O Ground State and the E2 S Factor of the ^{12}C(α,γ)^{16}O ReactionY P Shen, B Guo, R J deBoer, et al.
The New England Journal of Medicine|December 19, 2008
Dicer, Drosha, and outcomes in patients with ovarian cancerWilliam M Merritt, Yvonne G Lin, Liz Y Han, et al.
Journal of Viral Hepatitis|February 12, 2016
A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virusS H Ahn, Y S Lim, K S Lee, et al.
The American Journal of Tropical Medicine and Hygiene|July 27, 2022
Temporal Dynamics of Subclinical Malaria in Different Transmission Zones of MyanmarJoseph R Egger, Kay T Han, Huang Fang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|February 25, 2024
[Epidemiological characteristics of human respiratory syncytial virus among acute respiratory infection cases in 16 provinces of China from 2009 to 2023]A L Cui, B C Xia, Z Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Targeting aurora kinase with MK-0457 inhibits ovarian cancer growthYvonne G Lin, Anand Immaneni, William M Merritt, et al.
Science Advances|March 27, 2026
A synergistic interaction between PRMT5 and LSD1 inhibitors in AMLNesteene Joy Param, Elisa Arceci, Francesco Fiorentino, et al.
The British Journal of Surgery|August 24, 2019
Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or lessW Jung, T Park, Y Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2025
A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trialR A Soo, K Vervita, M Früh, et al.
Pageof 245